0000000000262717

AUTHOR

Gabriela G A Naufal

showing 1 related works from this author

Comment on “Chronic spontaneous urticaria exacerbation in a patient with COVID‐19: rapid and excellent response to omalizumab”

2020

medicine.medical_specialty2019-20 coronavirus outbreakUrticariaCoronavirus disease 2019 (COVID-19)ExacerbationSARS-CoV-2business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Symptom Flare UpTreatment outcomeMEDLINECOVID-19OmalizumabDermatologyOmalizumabInternal medicineAnti-Allergic AgentsCorrespondenceHumansMedicineChronic Urticariabusinessmedicine.drugInternational Journal of Dermatology
researchProduct